23.99 USD
+0.01 (+0.04%)
23.99 USD
0 (0%)
ABCM gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 534 industry peers in the Biotechnology industry. ABCM has an average financial health and profitability rating. ABCM is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
ABCM had positive earnings in the past year.
ABCM had a positive operating cash flow in the past year.
1.2 Ratios
ABCM's Return On Assets of 0.64% is amongst the best of the industry. ABCM outperforms 93.86% of its industry peers.
ABCM has a better Return On Equity (0.93%) than 93.86% of its industry peers.
The Return On Invested Capital of ABCM (1.98%) is better than 94.69% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ABCM is significantly below the industry average of 18.60%.
The 3 year average ROIC (6.00%) for ABCM is well above the current ROIC(1.98%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.64% | ||
| ROE | 0.93% | ||
| ROIC | 1.98% |
ROA(3y)4.53%
ROA(5y)8.06%
ROE(3y)5.58%
ROE(5y)9.64%
ROIC(3y)6%
ROIC(5y)8.74%
1.3 Margins
ABCM has a better Profit Margin (1.94%) than 94.86% of its industry peers.
In the last couple of years the Profit Margin of ABCM has declined.
ABCM has a better Operating Margin (8.70%) than 95.36% of its industry peers.
In the last couple of years the Operating Margin of ABCM has declined.
Looking at the Gross Margin, with a value of 72.69%, ABCM belongs to the top of the industry, outperforming 83.58% of the companies in the same industry.
In the last couple of years the Gross Margin of ABCM has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.7% | ||
| PM (TTM) | 1.94% | ||
| GM | 72.69% |
OM growth 3Y-28.84%
OM growth 5Y-15.57%
PM growth 3Y-41.13%
PM growth 5Y-24.24%
GM growth 3Y0.59%
GM growth 5Y0.27%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ABCM is destroying value.
The number of shares outstanding for ABCM has been increased compared to 1 year ago.
ABCM has a better debt/assets ratio than last year.
2.2 Solvency
ABCM has an Altman-Z score of 8.64. This indicates that ABCM is financially healthy and has little risk of bankruptcy at the moment.
ABCM has a better Altman-Z score (8.64) than 85.41% of its industry peers.
The Debt to FCF ratio of ABCM is 19.99, which is on the high side as it means it would take ABCM, 19.99 years of fcf income to pay off all of its debts.
ABCM has a Debt to FCF ratio of 19.99. This is amongst the best in the industry. ABCM outperforms 94.03% of its industry peers.
ABCM has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.30, ABCM is doing worse than 71.81% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 19.99 | ||
| Altman-Z | 8.64 |
ROIC/WACC0.22
WACC8.89%
2.3 Liquidity
ABCM has a Current Ratio of 1.26. This is a normal value and indicates that ABCM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.26, ABCM is doing worse than 86.73% of the companies in the same industry.
A Quick Ratio of 0.98 indicates that ABCM may have some problems paying its short term obligations.
ABCM has a worse Quick ratio (0.98) than 88.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 402.64% over the past year.
ABCM shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.30% yearly.
ABCM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.70%.
Measured over the past years, ABCM shows a quite strong growth in Revenue. The Revenue has been growing by 11.64% on average per year.
EPS 1Y (TTM)402.64%
EPS 3Y-38.1%
EPS 5Y-17.3%
EPS Q2Q%191.67%
Revenue 1Y (TTM)17.7%
Revenue growth 3Y8.48%
Revenue growth 5Y11.64%
Sales Q2Q%23.3%
3.2 Future
The Earnings Per Share is expected to grow by 40.12% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 11.28% on average over the next years. This is quite good.
EPS Next Y125.95%
EPS Next 2Y68.04%
EPS Next 3Y52.49%
EPS Next 5Y40.12%
Revenue Next Year24.37%
Revenue Next 2Y18.92%
Revenue Next 3Y16.75%
Revenue Next 5Y11.28%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 44.43, which means the current valuation is very expensive for ABCM.
Based on the Price/Earnings ratio, ABCM is valued cheaper than 94.69% of the companies in the same industry.
ABCM is valuated expensively when we compare the Price/Earnings ratio to 26.15, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 49.32, ABCM can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, ABCM is valued cheaply inside the industry as 94.53% of the companies are valued more expensively.
ABCM's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 36.22.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.43 | ||
| Fwd PE | 49.32 |
4.2 Price Multiples
ABCM's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ABCM is cheaper than 94.20% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ABCM is valued cheaper than 93.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 374.67 | ||
| EV/EBITDA | 55.61 |
4.3 Compensation for Growth
ABCM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ABCM has a very decent profitability rating, which may justify a higher PE ratio.
ABCM's earnings are expected to grow with 52.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y68.04%
EPS Next 3Y52.49%
5. Dividend
5.1 Amount
No dividends for ABCM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
23.99
+0.01 (+0.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners1.79%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.49B
Revenue(TTM)350.40M
Net Income(TTM)6.80M
Analysts80
Price Target20.23 (-15.67%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.43 | ||
| Fwd PE | 49.32 | ||
| P/S | 12.3 | ||
| P/FCF | 374.67 | ||
| P/OCF | 79.64 | ||
| P/B | 5.92 | ||
| P/tB | 42.37 | ||
| EV/EBITDA | 55.61 |
EPS(TTM)0.54
EY2.25%
EPS(NY)0.49
Fwd EY2.03%
FCF(TTM)0.06
FCFY0.27%
OCF(TTM)0.3
OCFY1.26%
SpS1.95
BVpS4.05
TBVpS0.57
PEG (NY)0.35
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.64% | ||
| ROE | 0.93% | ||
| ROCE | 3.54% | ||
| ROIC | 1.98% | ||
| ROICexc | 2.23% | ||
| ROICexgc | 7.95% | ||
| OM | 8.7% | ||
| PM (TTM) | 1.94% | ||
| GM | 72.69% | ||
| FCFM | 3.28% |
ROA(3y)4.53%
ROA(5y)8.06%
ROE(3y)5.58%
ROE(5y)9.64%
ROIC(3y)6%
ROIC(5y)8.74%
ROICexc(3y)7.76%
ROICexc(5y)11.54%
ROICexgc(3y)24.8%
ROICexgc(5y)47.7%
ROCE(3y)9.88%
ROCE(5y)14%
ROICexgc growth 3Y-57.08%
ROICexgc growth 5Y-37.19%
ROICexc growth 3Y-42.21%
ROICexc growth 5Y-23.94%
OM growth 3Y-28.84%
OM growth 5Y-15.57%
PM growth 3Y-41.13%
PM growth 5Y-24.24%
GM growth 3Y0.59%
GM growth 5Y0.27%
F-Score5
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 19.99 | ||
| Debt/EBITDA | 2.79 | ||
| Cap/Depr | 90.64% | ||
| Cap/Sales | 12.16% | ||
| Interest Coverage | 9.53 | ||
| Cash Conversion | 69.81% | ||
| Profit Quality | 169.12% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | 8.64 |
F-Score5
WACC8.89%
ROIC/WACC0.22
Cap/Depr(3y)181.11%
Cap/Depr(5y)191.67%
Cap/Sales(3y)16.16%
Cap/Sales(5y)14.67%
Profit Quality(3y)125.12%
Profit Quality(5y)105.69%
High Growth Momentum
Growth
EPS 1Y (TTM)402.64%
EPS 3Y-38.1%
EPS 5Y-17.3%
EPS Q2Q%191.67%
EPS Next Y125.95%
EPS Next 2Y68.04%
EPS Next 3Y52.49%
EPS Next 5Y40.12%
Revenue 1Y (TTM)17.7%
Revenue growth 3Y8.48%
Revenue growth 5Y11.64%
Sales Q2Q%23.3%
Revenue Next Year24.37%
Revenue Next 2Y18.92%
Revenue Next 3Y16.75%
Revenue Next 5Y11.28%
EBIT growth 1Y-18.45%
EBIT growth 3Y-22.8%
EBIT growth 5Y-5.74%
EBIT Next Year197.84%
EBIT Next 3Y63.16%
EBIT Next 5Y39.34%
FCF growth 1Y-42.5%
FCF growth 3Y-17.2%
FCF growth 5Y-14.26%
OCF growth 1Y66.98%
OCF growth 3Y4.34%
OCF growth 5Y8.73%
ABCAM PLC-SPON ADR / ABCM FAQ
Can you provide the ChartMill fundamental rating for ABCAM PLC-SPON ADR?
ChartMill assigns a fundamental rating of 6 / 10 to ABCM.
What is the valuation status for ABCM stock?
ChartMill assigns a valuation rating of 7 / 10 to ABCAM PLC-SPON ADR (ABCM). This can be considered as Undervalued.
How profitable is ABCAM PLC-SPON ADR (ABCM) stock?
ABCAM PLC-SPON ADR (ABCM) has a profitability rating of 8 / 10.
What is the earnings growth outlook for ABCAM PLC-SPON ADR?
The Earnings per Share (EPS) of ABCAM PLC-SPON ADR (ABCM) is expected to grow by 125.95% in the next year.
Is the dividend of ABCAM PLC-SPON ADR sustainable?
The dividend rating of ABCAM PLC-SPON ADR (ABCM) is 0 / 10 and the dividend payout ratio is 0%.